QQQ   428.97 (-0.49%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   428.97 (-0.49%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   428.97 (-0.49%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)
QQQ   428.97 (-0.49%)
AAPL   169.38 (-1.92%)
MSFT   414.58 (+0.23%)
META   499.76 (-0.09%)
GOOGL   154.40 (-0.30%)
AMZN   183.32 (-0.16%)
TSLA   157.11 (-2.71%)
NVDA   874.15 (+1.64%)
AMD   163.46 (+1.96%)
NIO   3.81 (-2.06%)
BABA   69.61 (-1.43%)
T   16.09 (-0.92%)
F   12.09 (-1.14%)
MU   121.77 (+0.33%)
GE   156.76 (+1.99%)
CGC   6.70 (-4.01%)
DIS   113.88 (+0.82%)
AMC   2.72 (+10.12%)
PFE   25.69 (-0.85%)
PYPL   63.43 (-0.13%)
XOM   118.69 (-0.83%)

Avidity Biosciences (RNA) News Today

$24.01
+0.10 (+0.42%)
(As of 11:15 AM ET)
SourceHeadline
marketbeat.com logoRaymond James Financial Services Advisors Inc. Raises Stock Position in Avidity Biosciences, Inc. (NASDAQ:RNA)
marketbeat.com - April 17 at 4:11 AM
msn.com logoUnveiling the key role of RNA modification in HIV-1 survival and replication
msn.com - April 13 at 8:29 AM
MarketBeat logoAvidity Biosciences (NASDAQ:RNA) Rating Reiterated by Needham & Company LLC
americanbankingnews.com - April 13 at 6:16 AM
marketbeat.com logoVanguard Group Inc. Acquires 47,305 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
marketbeat.com - April 13 at 4:31 AM
markets.businessinsider.com logoAnalysts Offer Insights on Healthcare Companies: Carisma Therapeutics (CARM), Avidity Biosciences (RNA) and Vera Therapeutics (VERA)
markets.businessinsider.com - April 11 at 1:39 PM
marketbeat.com logoSG Americas Securities LLC Invests $377,000 in Avidity Biosciences, Inc. (NASDAQ:RNA)
marketbeat.com - April 8 at 4:09 AM
insidertrades.com logoArthur A. Levin Sells 20,000 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) Stock
insidertrades.com - April 5 at 5:04 AM
marketbeat.com logoAvidity Biosciences (NASDAQ:RNA) Shares Down 2.7% Following Insider Selling
marketbeat.com - April 4 at 11:55 AM
finance.yahoo.com logoInsider Sell: Avidity Biosciences Inc (RNA) President and CEO Sarah Boyce Sells 28,000 Shares
finance.yahoo.com - April 4 at 11:11 AM
marketbeat.com logoAvidity Biosciences, Inc. (NASDAQ:RNA) Director Arthur A. Levin Sells 20,000 Shares
marketbeat.com - April 3 at 9:19 PM
marketbeat.com logoAvidity Biosciences (NASDAQ:RNA) Hits New 52-Week High at $26.62
marketbeat.com - April 1 at 5:51 PM
prnewswire.com logoAvidity Biosciences to Participate in Upcoming Investor Conferences
prnewswire.com - March 27 at 9:00 AM
finance.yahoo.com logoRNA Apr 2024 17.500 call
finance.yahoo.com - March 17 at 5:14 AM
finance.yahoo.com logoRNA Apr 2024 17.500 put
finance.yahoo.com - March 16 at 12:35 PM
insidertrades.com logoAvidity Biosciences, Inc. (NASDAQ:RNA) CFO Sells $980,800.00 in Stock
insidertrades.com - March 16 at 8:42 AM
finance.yahoo.com logoRNA Apr 2024 22.500 call
finance.yahoo.com - March 16 at 2:35 AM
finance.yahoo.com logoInsider Sell: CFO Michael Maclean Sells 40,000 Shares of Avidity Biosciences Inc (RNA)
finance.yahoo.com - March 15 at 9:34 PM
marketbeat.com logoInsider Selling: Avidity Biosciences, Inc. (NASDAQ:RNA) CFO Sells 40,000 Shares of Stock
marketbeat.com - March 15 at 4:46 PM
marketbeat.com logoAvidity Biosciences (NASDAQ:RNA) Coverage Initiated at Cantor Fitzgerald
marketbeat.com - March 14 at 8:38 AM
insidertrades.com logoAvidity Biosciences, Inc. (NASDAQ:RNA) Director Sells $608,931.23 in Stock
insidertrades.com - March 13 at 6:40 AM
marketbeat.com logoInsider Selling: Avidity Biosciences, Inc. (NASDAQ:RNA) Director Sells 27,641 Shares of Stock
marketbeat.com - March 12 at 10:29 PM
marketbeat.com logoAvidity Biosciences (NASDAQ:RNA) Reaches New 1-Year High at $22.55
marketbeat.com - March 12 at 3:36 PM
marketbeat.com logoAdage Capital Partners GP L.L.C. Boosts Stake in Avidity Biosciences, Inc. (NASDAQ:RNA)
marketbeat.com - March 10 at 6:37 AM
marketbeat.com logoAvidity Biosciences (NASDAQ:RNA) Trading 6.2% Higher
marketbeat.com - March 8 at 12:43 PM
marketbeat.com logoChardan Capital Weighs in on Avidity Biosciences, Inc.'s FY2024 Earnings (NASDAQ:RNA)
marketbeat.com - March 8 at 7:21 AM
marketbeat.com logoAvidity Biosciences, Inc. (NASDAQ:RNA) Receives Consensus Recommendation of "Buy" from Brokerages
marketbeat.com - March 8 at 3:25 AM
markets.businessinsider.com logoAvidity Biosciences: Strong Buy Rating Amidst Positive Clinical Developments and Price Target Surge
markets.businessinsider.com - March 7 at 4:53 PM
marketbeat.com logoGSA Capital Partners LLP Has $2.17 Million Position in Avidity Biosciences, Inc. (NASDAQ:RNA)
marketbeat.com - March 7 at 9:45 AM
marketbeat.com logoAvidity Biosciences, Inc. (NASDAQ:RNA) to Post Q1 2024 Earnings of ($0.78) Per Share, Leerink Partnrs Forecasts
marketbeat.com - March 7 at 6:40 AM
seekingalpha.com logoAvidity Biosciences: Targeting A First Ever Approval In DM1 With Improving Data
seekingalpha.com - March 5 at 1:27 PM
markets.businessinsider.com logoA Closer Look at 5 Analyst Recommendations For Avidity Biosciences
markets.businessinsider.com - March 5 at 7:58 AM
markets.businessinsider.com logoBuy Rating Affirmed for Avidity Biosciences Following Promising MARINA-OLE Study Data and RNA Analysis
markets.businessinsider.com - March 5 at 2:58 AM
markets.businessinsider.com logoBuy Rating Affirmed: Avidity Biosciences’s Promising MARINA-OLE Trial Data Indicates Significant DM1 Treatment Breakthrough
markets.businessinsider.com - March 4 at 4:52 PM
msn.com logoAvidity Biosciences Says Lead Program Shows Reversal Of Disease Progression In Neuromuscular Disease
msn.com - March 4 at 4:52 PM
markets.businessinsider.com logoAvidity Accelerates Phase 3 HARBOR Study Initiation To Q2 - Quick Facts
markets.businessinsider.com - March 4 at 11:51 AM
finance.yahoo.com logoAvidity Biosciences Announces Positive AOC 1001 Long-term Data Showing Reversal of Disease Progression in People Living with Myotonic Dystrophy Type 1 Across Multiple Endpoints; Same Key Endpoints Agreed for Phase 3 HARBOR™ Trial
finance.yahoo.com - March 4 at 11:51 AM
finance.yahoo.com logoTop 2% Biotech Avidity Collapses Despite 'Positive' Results In Treating Muscular Dystrophy
finance.yahoo.com - March 4 at 11:51 AM
investing.com logoAvidity Biosciences secures $400 million in private placement
investing.com - March 2 at 5:33 PM
marketbeat.com logoAvidity Biosciences (NASDAQ:RNA) Stock Price Up 9.2%
marketbeat.com - March 1 at 3:14 PM
marketbeat.com logoLeerink Partnrs Comments on Avidity Biosciences, Inc.'s FY2025 Earnings (NASDAQ:RNA)
marketbeat.com - March 1 at 8:45 AM
finance.yahoo.com logoAvidity Biosciences Full Year 2023 Earnings: Misses Expectations
finance.yahoo.com - March 1 at 8:39 AM
marketbeat.com logoProfund Advisors LLC Cuts Stock Holdings in Avidity Biosciences, Inc. (NASDAQ:RNA)
marketbeat.com - March 1 at 6:26 AM
edition.cnn.com logoAvidity Biosciences Inc
edition.cnn.com - February 29 at 8:17 PM
seekingalpha.com logoAvidity Biosciences: DMD Advancement And 2024 Catalysts Make It A Must-Watch
seekingalpha.com - February 29 at 3:17 PM
prnewswire.com logoAvidity Biosciences Honors Rare Disease Day®
prnewswire.com - February 29 at 12:00 PM
finanznachrichten.de logoAvidity Biosciences, Inc.: Avidity Biosciences Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Highlights
finanznachrichten.de - February 29 at 10:16 AM
markets.businessinsider.com logoTD Cowen Reaffirms Their Buy Rating on Avidity Biosciences (RNA)
markets.businessinsider.com - February 29 at 10:16 AM
prnewswire.com logoAvidity Biosciences Announces Oversubscribed $400 Million Private Placement
prnewswire.com - February 29 at 7:00 AM
marketbeat.com logoFmr LLC Buys 491,567 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA)
marketbeat.com - February 29 at 5:29 AM
finance.yahoo.com logoAvidity Biosciences Inc (RNA) Reports Year-End Financials and Clinical Progress
finance.yahoo.com - February 29 at 12:01 AM
Get Avidity Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for RNA and its competitors with MarketBeat's FREE daily newsletter.

Red Alert: Your Money's Disappearance Act - Banks' Greed Unleashed! (Ad)

Get your free information kit NOW, before it’s too late. Inside you’ll get the 3 secret strategies you can put in place starting today, so “they” don’t get your money tomorrow.

Click here for your free guide

RNA Media Mentions By Week

RNA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

RNA
News Sentiment

0.66

0.43

Average
Medical
News Sentiment

RNA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

RNA Articles
This Week

6

3

RNA Articles
Average Week

Get Avidity Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for RNA and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:RNA) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners